Concepedia

Author

Nazzareno Dimasi

Istituto Giannina GasliniORCID

Also Known As

N Dimasi, N. Dimasi, Nazzareno Dimasi

152

Publications

3.7K

Citations

33

H-Index

72

Concepts

All Affiliations

Istituto Giannina GasliniAstraZeneca (Germany)Spirogen (United Kingdom)Altimmune (United States)National Institutes of Health
ND

About

Nazzareno Dimasi is an author at Istituto Giannina Gaslini specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

24

1.5K

2

Natural Sciences

13

14

627

3

Biochemistry

11

11

409

4

Engineering

4

4

138

5

Biomedical Engineering

2

2

36

Nazzareno Dimasi

×

45

Publications

2.8K

Citations

28

H-Index

YearCitations

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina,

Cancer Cell

2016

375

A multifunctional bispecific antibody protects against <i>Pseudomonas aeruginosa</i>

Antonio DiGiandomenico, Ashley Keller, Cuihua Gao,

Science Translational Medicine

2014

272

Crystal Structure of a Superantigen Bound to the High-Affinity, Zinc-Dependent Site on MHC Class II

Yili Li, Hongmin Li, Nazzareno Dimasi,

Immunity

2001

135

Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb

Julie Dam, Rongjin Guan, Kannan Natarajan,

Nature Immunology

2003

133

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein,

Cancer Research

2017

124

Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides

R. James Christie, Ryan Fleming, Binyam Bezabeh,

Journal of Controlled Release

2015

122

Binding Specificity of Multiprotein Signaling Complexes Is Determined by Both Cooperative Interactions and Affinity Preferences

Jon C. D. Houtman, Yuichiro Higashimoto, Nazzareno Dimasi,

Biochemistry

2004

111

The Design and Characterization of Oligospecific Antibodies for Simultaneous Targeting of Multiple Disease Mediators

Nazzareno Dimasi, Changshou Gao, Ryan Fleming,

Journal of Molecular Biology

2009

92

Affinity selection of a camelized V(H) domain antibody inhibitor of hepatitis C virus NS3 protease

Franck Martin, Cinzia Volpari, Christian Steinkühler,

Protein Engineering Design and Selection

1997

88

SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads

Krista Kinneer, John Meekin, Arnaud Tiberghien,

Clinical Cancer Research

2018

81

Page 1